Khiron Pharma Commerce ApS: Financial statements 2020
CVR: 37003204
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Khiron Pharma Commerce ApS (CVR 37003204) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -32,918 and a net result of DKK -68,671 compared with DKK 64,388 the year before. Equity in the 2020 report amounted to DKK 45,073. The solvency ratio was 59.7%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -32,918
- Profit/Loss
- DKK -68,671
- Equity
- DKK 45,073
- Total Assets
- DKK 75,551
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -33 t. | -69 t. | 45 t. | 1 |
| 2019 | - | 218 t. | 64 t. | 114 t. | 1 |
| 2018 | - | 164 t. | 17 t. | 49 t. | 1 |
| 2017 | - | 240 t. | 50 t. | 32 t. | 1 |
Official annual report
How creditworthy is Khiron Pharma Commerce ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Khiron Pharma Commerce ApS has published its annual report for 2019. Gross profit came to DKK 218,079, and the net result was DKK 64,388.
About Khiron Pharma Commerce ApS
Khiron Pharma Commerce ApS is a Danish company of the type Anpartsselskab based in Frederiksværk, founded in 2015. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Dan Henning Norden and Lone Lindquist-Nielsen. The company's owners include Lone Lindquist-Nielsen, Dan Henning Norden and Mette Rokkedal. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 780,426 and a net result of DKK 339,637 compared with DKK 4,240 the year before. Equity in the 2025 report amounted to DKK 515,211.